Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill M Spoerke

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Evolution; International Journal of Organic Evolution|June 1, 2017
DIVERGENCE IN SYMBIOTIC COMPATIBILITY IN A LEGUME-BRADYRHIZOBIUM MUTUALISMHeather H Wilkinson, Jill M Spoerke, Matthew A Parker
Evolution; International Journal of Organic Evolution|June 2, 2017
NONRANDOM GENOTYPIC ASSOCIATIONS IN A LEGUME-BRADYRHIZOBIUM MUTUALISMJill M Spoerke, Heather H Wilkinson, Matthew A Parker
Cancer Research|January 14, 2016
Activating Mutations in PIK3CB Confer Resistance to PI3K Inhibition and Define a Novel Oncogenic Role for p110βYoshito Nakanishi, Kimberly Walter, Jill M Spoerke, et al.
Micropublication Biology|December 19, 2022
<i>om92</i> , a <i>glp-1</i> enhancer mutation, is an allele of <i>ekl-1</i>Samantha A Stein, Olivia F Zucaro, Harold E Smith, et al.
Molecular Cancer Research : MCR|September 2, 2018
Genomic Alterations Associated with Recurrence and TNBC Subtype in High-Risk Early Breast CancersTimothy R Wilson, Akshata R Udyavar, Ching-Wei Chang, et al.
Breast Cancer Research : BCR|September 7, 2018
A phase Ib study of pictilisib (GDC-0941) in combination with paclitaxel, with and without bevacizumab or trastuzumab, and with letrozole in advanced breast cancerPatrick Schöffski, Sara Cresta, Ingrid A Mayer, et al.
Plos One|September 15, 2010
Molecular biomarker analyses using circulating tumor cellsElizabeth A Punnoose, Siminder K Atwal, Jill M Spoerke, et al.
The Oncologist|August 12, 2017
A Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of Pictilisib in Combination with Erlotinib in Patients with Advanced Solid TumorsStephen Leong, Rebecca A Moss, Daniel W Bowles, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2019
Low-pass Whole-genome Sequencing of Circulating Cell-free DNA Demonstrates Dynamic Changes in Genomic Copy Number in a Squamous Lung Cancer Clinical CohortXiaoji Chen, Ching-Wei Chang, Jill M Spoerke, et al.
Breast Cancer Research and Treatment|October 23, 2014
Development of a robust RNA-based classifier to accurately determine ER, PR, and HER2 status in breast cancer clinical samplesTimothy R Wilson, Yuanyuan Xiao, Jill M Spoerke, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Evolution; International Journal of Organic Evolution|June 1, 2017
DIVERGENCE IN SYMBIOTIC COMPATIBILITY IN A LEGUME-BRADYRHIZOBIUM MUTUALISMHeather H Wilkinson, Jill M Spoerke, Matthew A Parker
Evolution; International Journal of Organic Evolution|June 2, 2017
NONRANDOM GENOTYPIC ASSOCIATIONS IN A LEGUME-BRADYRHIZOBIUM MUTUALISMJill M Spoerke, Heather H Wilkinson, Matthew A Parker
Cancer Research|January 14, 2016
Activating Mutations in PIK3CB Confer Resistance to PI3K Inhibition and Define a Novel Oncogenic Role for p110βYoshito Nakanishi, Kimberly Walter, Jill M Spoerke, et al.
Micropublication Biology|December 19, 2022
<i>om92</i> , a <i>glp-1</i> enhancer mutation, is an allele of <i>ekl-1</i>Samantha A Stein, Olivia F Zucaro, Harold E Smith, et al.
Molecular Cancer Research : MCR|September 2, 2018
Genomic Alterations Associated with Recurrence and TNBC Subtype in High-Risk Early Breast CancersTimothy R Wilson, Akshata R Udyavar, Ching-Wei Chang, et al.
Breast Cancer Research : BCR|September 7, 2018
A phase Ib study of pictilisib (GDC-0941) in combination with paclitaxel, with and without bevacizumab or trastuzumab, and with letrozole in advanced breast cancerPatrick Schöffski, Sara Cresta, Ingrid A Mayer, et al.
Plos One|September 15, 2010
Molecular biomarker analyses using circulating tumor cellsElizabeth A Punnoose, Siminder K Atwal, Jill M Spoerke, et al.
The Oncologist|August 12, 2017
A Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of Pictilisib in Combination with Erlotinib in Patients with Advanced Solid TumorsStephen Leong, Rebecca A Moss, Daniel W Bowles, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2019
Low-pass Whole-genome Sequencing of Circulating Cell-free DNA Demonstrates Dynamic Changes in Genomic Copy Number in a Squamous Lung Cancer Clinical CohortXiaoji Chen, Ching-Wei Chang, Jill M Spoerke, et al.
Breast Cancer Research and Treatment|October 23, 2014
Development of a robust RNA-based classifier to accurately determine ER, PR, and HER2 status in breast cancer clinical samplesTimothy R Wilson, Yuanyuan Xiao, Jill M Spoerke, et al.
Pageof 3